ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1,113 Cr | ₹881 Cr | ₹92 Cr | ₹285 Cr | ₹269 Cr |
What is the latest Contingent Liabilities ratio of ALKEM LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹1,113 Cr |
| Mar2025 | ₹881 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹285 Cr |
| Mar2022 | ₹269 Cr |
How is Contingent Liabilities of ALKEM LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,113 Cr | 26.34 | |
| Mar2025 | ₹881 Cr | 860.69 | |
| Mar2024 | ₹92 Cr | -67.77 | |
| Mar2023 | ₹285 Cr | 5.93 | |
| Mar2022 | ₹269 Cr | - | |
Compare Contingent Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹61,546.2 Cr | -3.5% | -3.9% | -6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -3.5% |
-3.9% |
-6.1% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses